E-LIB Suche - Ergebnisse für: Schmidinger, M.

1

Efficacy of avelumab plus axitinib versus sunitinib by numb..:

Tomita, Y ; Motzer, R.J ; Choueiri, T.K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774904/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Extended follow-up from JAVELIN Renal 101: subgroup analysi..:

Haanen, J.B.A.G ; Larkin, J ; Choueiri, T.K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265611/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Efficacy and safety of avelumab plus axitinib in elderly pa..:

Tomita, Y ; Motzer, R.J ; Choueiri, T.K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058903/. , 2022

Link: http://www.ncbi.nlm.nih...

4

First-line treatment of metastatic clear cell renal cell ca..:

Aeppli, S ; Schmaus, M ; Eisen, T...
ARTN 100030. , 2022

Link: https://repository.icr.a..

5

Impact of COVID-19 pandemic on treatment patterns in metast..:

Aeppli, S ; Eboulet, EI ; Eisen, T...
ARTN e000852. , 2022

Link: https://repository.icr.a..

6

Real-world Experience With Sunitinib Treatment in Patients ..:

Schmidinger, M ; Porta, C ; Oudard, S...
S1558-7673(20)30047-1. , 2022

Link: https://repository.icr.a..

7

Prospective Cardiovascular Surveillance of Immune Checkpoin..:

Rini, BI ; Moslehi, JJ ; Bonaca, M...
Journal of Clinical Oncology, 2022, 40 (17), pp. 1929 - 1938. , 2022

Link: https://repository.icr.a..

8

First-line treatment of metastatic clear cell renal cell ca..:

Aeppli, S ; Schmaus, M ; Eisen, T...
https://boris.unibe.ch/160787/. , 2021

Link: https://boris.unibe.ch/1..

9

ESMO Open / Outcome of immune checkpoint inhibitors in meta..:

Resch, I ; Bruchbacher, A ; Franke, J...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-49912/128. , 2021

Link: https://doi.org/10.1016/..

10

Pan-Asian adapted ESMO Clinical Practice Guidelines for the..:

Kanesvaran, R ; Porta, C ; Wong, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645910/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Tumor mutational burden and immune infiltrates in renal cel..:

Steindl, A ; Alpar, D ; Heller, G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890370/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Pan-Asian adapted ESMO Clinical Practice Guidelines for the..:

Kanesvaran, R ; Porta, C ; Wong, A...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2021.100304. , 2021

Link: https://serval.unil.ch/n..

13

Pan-Asian adapted ESMO Clinical Practice Guidelines for the..:

Kanesvaran R ; Porta C ; Wong A...
info:eu-repo/semantics/altIdentifier/pmid/34864348. , 2021

Link: http://hdl.handle.net/24..

14

Updated efficacy results from the JAVELIN Renal 101 trial: ..:

Choueiri, T K ; Motzer, R J ; Rini, B I...
https://eprints.gla.ac.uk/284663/1/284663.pdf. , 2020

Link: https://eprints.gla.ac.u..

15

Updated efficacy results from the JAVELIN Renal 101 trial: ..:

Choueiri, TK ; Motzer, RJ ; Rini, BI...
Annals of oncology : official journal of the European Society for Medical Oncology, 2020, 31 (8), pp. 1030 - 1039. , 2020

Link: https://repository.icr.a..